TheStreet’s Jim Cramer says the departure of a high ranking FDA official is good news for Sarepta Therapeutics ( ). Dr. Ronald Farkas left the FDA for the private sector last week.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
